<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bauer TA</submitter><funding>Bundesministerium für Bildung und Forschung</funding><funding>Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg</funding><funding>Deutsche Forschungsgemeinschaft</funding><funding>Max-Planck-Gesellschaft</funding><pagination>e2100385</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11468145</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(19)</volume><pubmed_abstract>Iron is an essential co-factor for cellular processes. In the immune system, it can activate macrophages and represents a potential therapeutic for various diseases. To specifically deliver iron to macrophages, iron oxide nanoparticles are embedded in polymeric micelles of reactive polysarcosine-block-poly(S-ethylsulfonyl-l-cysteine). Upon surface functionalization via dihydrolipoic acid, iron oxide cores act as crosslinker themselves and undergo chemoselective disulfide bond formation with the surrounding poly(S-ethylsulfonyl-l-cysteine) block, yielding glutathione-responsive core cross-linked polymeric micelles (CCPMs). When applied to primary murine and human macrophages, these nanoparticles display preferential uptake, sustained intracellular iron release, and induce a strong inflammatory response. This response is also demonstrated in vivo when nanoparticles are intratracheally administered to wild-type C57Bl/6N mice. Most importantly, the controlled release concept to deliver iron oxide in redox-responsive CCPMs induces significantly stronger macrophage activation than any other iron source at identical iron levels (e.g., Feraheme), directing to a new class of immune therapeutics.</pubmed_abstract><journal>Advanced healthcare materials</journal><pubmed_title>Core Cross-Linked Polymeric Micelles for Specific Iron Delivery: Inducing Sterile Inflammation in Macrophages.</pubmed_title><pmcid>PMC11468145</pmcid><funding_grant_id>SFB1036</funding_grant_id><funding_grant_id>Nr 031L0191C</funding_grant_id><funding_grant_id>SFB1118</funding_grant_id><funding_grant_id>DZL TLRC‐H</funding_grant_id><funding_grant_id>SFB1066</funding_grant_id><pubmed_authors>Koynov K</pubmed_authors><pubmed_authors>Sotillo R</pubmed_authors><pubmed_authors>Hentze MW</pubmed_authors><pubmed_authors>Chocarro S</pubmed_authors><pubmed_authors>Carrella LM</pubmed_authors><pubmed_authors>Morsbach S</pubmed_authors><pubmed_authors>Schmitt S</pubmed_authors><pubmed_authors>Horvat NK</pubmed_authors><pubmed_authors>Colucci S</pubmed_authors><pubmed_authors>Mertens C</pubmed_authors><pubmed_authors>Barz M</pubmed_authors><pubmed_authors>Blumler P</pubmed_authors><pubmed_authors>Fenaroli F</pubmed_authors><pubmed_authors>Jung M</pubmed_authors><pubmed_authors>Muckenthaler MU</pubmed_authors><pubmed_authors>Bauer TA</pubmed_authors><pubmed_authors>Marques O</pubmed_authors></additional><is_claimable>false</is_claimable><name>Core Cross-Linked Polymeric Micelles for Specific Iron Delivery: Inducing Sterile Inflammation in Macrophages.</name><description>Iron is an essential co-factor for cellular processes. In the immune system, it can activate macrophages and represents a potential therapeutic for various diseases. To specifically deliver iron to macrophages, iron oxide nanoparticles are embedded in polymeric micelles of reactive polysarcosine-block-poly(S-ethylsulfonyl-l-cysteine). Upon surface functionalization via dihydrolipoic acid, iron oxide cores act as crosslinker themselves and undergo chemoselective disulfide bond formation with the surrounding poly(S-ethylsulfonyl-l-cysteine) block, yielding glutathione-responsive core cross-linked polymeric micelles (CCPMs). When applied to primary murine and human macrophages, these nanoparticles display preferential uptake, sustained intracellular iron release, and induce a strong inflammatory response. This response is also demonstrated in vivo when nanoparticles are intratracheally administered to wild-type C57Bl/6N mice. Most importantly, the controlled release concept to deliver iron oxide in redox-responsive CCPMs induces significantly stronger macrophage activation than any other iron source at identical iron levels (e.g., Feraheme), directing to a new class of immune therapeutics.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2025-04-18T14:09:32.937Z</modification><creation>2025-04-04T19:38:16.72Z</creation></dates><accession>S-EPMC11468145</accession><cross_references><pubmed>34137217</pubmed><doi>10.1002/adhm.202100385</doi></cross_references></HashMap>